期刊文献+

慢性乙型肝炎患者外周血白蛋白mRNA表达

下载PDF
导出
摘要 目的研究慢性乙型肝炎患者外周血白蛋白mRNA表达与病变程度的关系。方法采用荧光定量PCR和逆转录巢式PCR分别检测慢性乙型肝炎患者血清HBV DNA和外周血单个核细胞(PBMNC)中白蛋白mRNA的表达。结果26例慢性肝炎活动期患者中,血清HBV DNA阳性率为100%,HBVDNA含量为5.35(1.02-7.01)×10^8copies/ml;外周血单个核细胞白蛋白mRNA阳性率为57.7%,阳性者肝脏炎症反应较严重。20例慢性肝炎静止期患者中,血清HBVDNA全部阴性(〈1×10^3lopies/ml),外周血单个核细胞中的白蛋白mRNA阳性率为10%。慢性肝炎活动期和静止期患者外周血单个核细胞中的白蛋白mRNA阳性率差异有显著性(P〈0.05)。结论血清HBVDNA与慢性乙型肝炎活动性密切相关;外周血单个核细胞中的白蛋白mRNA表达与肝脏损害相关,二者均是临床疗效评价的重要指标。
出处 《广东医学》 CAS CSCD 北大核心 2008年第4期610-612,共3页 Guangdong Medical Journal
基金 广东省自然科学基金资助项目(编号:05003906)
  • 相关文献

参考文献6

二级参考文献25

  • 1Zoulim F. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.Antiviral Res, 2004, 64: 1-15.
  • 2Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA. J Hepatol, 2005, 42: 302-308.
  • 3Werle-Lapostolle B, Bowden S, Locarnini S, et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology, 2004,126: 1750-1758.
  • 4Yuen MF, Wong DK, Sum SS, et al. Effect of Lamivudine Therapy on the Serum Covalently Closed-Circular (ccc) DNA of Chronic Hepatitis B Infection. Am J Gastroenterol, 2005, 100: 1099-1103.
  • 5Akuta N, Suzuki F, Suzuki Y, et al. Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study. J Med Virol, 2005, 75: 491-498.
  • 6Yuen MF, Chow DH, Tsui K, et al. Liver histology of Asian patients with chronic hepatitis B on prolonged lamivudine therapy. Aliment Pharmacol Ther, 2005, 21: 841-849.
  • 7Lai CL, Rosmawati M, Lao J, et al. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection. Gastroenterology, 2002, 123: 1831-1838.
  • 8Levine S, Hernandez D, Yamanaka G, et al. Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro. Antimicrob Agents Chemother,2002, 46: 2525-2532.
  • 9Tenney DJ, Levine SM, Rose RE, et al. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother, 2004, 48: 3498-3507.
  • 10Zoulim F. Combination of nucleoside analogues in the treatment of chronic hepatitis B virus infection: lesson from experimental models.J Antimicrob Chemother, 2005, 55:608-611.

共引文献14015

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部